RhumbLine Advisers’s Transphorm, Inc. Common Stock TGAN Stock Holding History

RhumbLine Advisers’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-31,663	Closed	-$155K	–	4388
2024 Q1	$155K	Buy	31,663 +1,146	+4%	+$5.44K	﹤0.01%	3284
2023 Q4	$111K	Buy	30,517 +332	+1%	+$909	﹤0.01%	3417
2023 Q3	$67K	Sell	30,185 -209	-0.7%	-$583	﹤0.01%	3580
2023 Q2	$103K	Buy	30,394 +3,384	+13%	+$12.2K	﹤0.01%	3514
2023 Q1	$108K	Buy	27,010 +915	+4%	+$4.03K	﹤0.01%	2847
2022 Q4	$142K	Buy	26,095 +981	+4%	+$5.77K	﹤0.01%	2856
2022 Q3	$126K	Buy	25,114 +1,930	+8%	+$9.5K	﹤0.01%	2977
2022 Q2	$88K	Buy	+23,184	New	+$148K	﹤0.01%	3037

RhumbLine Advisers's TGAN Position: Q2 2024 in Review

RhumbLine Advisers sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 31,663 shares — an estimated $155K sold.

RhumbLine Advisers first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $155K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

RhumbLine Advisers reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
RhumbLine Advisers sold 31,663 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $155K.
RhumbLine Advisers first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
RhumbLine Advisers's Transphorm, Inc. Common Stock position peaked at $155K in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.